P06213 (INSR_HUMAN) Homo sapiens (Human)

Insulin receptor UniProtKBInterproStringInteractive Modelling

1382 aa; Sequence (Fasta) ; (Isoform 2; )

Sequence Features

 1159Proton donor/acceptor.
 66Insulin-binding.
 551Interchain.
 2A -> G (in dbSNP:rs7508518). VAR_058395 dbSNP
 42N -> K (in RMS; impairs transport to the plasma membrane and reduces the affinity to bind insulin; dbSNP:rs121913143). VAR_004079 dbSNP
 55V -> A (in LEPRCH; Verona-1; dbSNP:rs121913152). VAR_004080 dbSNP
 58G -> R (in LEPRCH; Helmond; inhibits processing and transport; dbSNP:rs52836744). VAR_004081 dbSNP
 86D -> G (in IRAN type A). VAR_015907
 89L -> P (in IRAN type A). VAR_015908
 113R -> P (in LEPRCH; Atlanta-1; abolishes insulin binding; dbSNP:rs121913153). VAR_004082 dbSNP
 119A -> V (in LEPRCH; markedly impairs insulin binding). VAR_015909
 120L -> Q (in LEPRCH; inhibits receptor processing). VAR_031518
 146I -> M (in LEPRCH; mild; dbSNP:rs121913159). VAR_015539 dbSNP
 167V -> L (in IRAN type A). VAR_015910
 171Y -> H (in dbSNP:rs1051692). VAR_058396 dbSNP
 220P -> L (in Ins resistance; severe; dbSNP:rs749094324). VAR_004083 dbSNP
 228C -> R (in a gastric adenocarcinoma sample; somatic mutation). VAR_041429
 236H -> R (in RMS and LEPRCH; Winnipeg; may impair receptor processing; dbSNP:rs121913145). VAR_004084 dbSNP
 260L -> P (in LEPRCH; Geldeimalsen; dbSNP:rs121913141). VAR_004085 dbSNP
 279R -> C (in IRAN type A; inhibits receptor internalization). VAR_015540
 279R -> H (in IRAN type A; interferes with receptor processing). VAR_031519
 280C -> Y (in IRAN type A). VAR_015911
 301C -> Y (in LEPRCH). VAR_015912
 308Missing (in LEPRCH; abolishes insulin binding). VAR_015913
 350S -> L (in RMS and LEPRCH). VAR_015914
 362Missing (in LEPRCH). VAR_015541
 386G -> S (in RMS; may impair receptor processing; dbSNP:rs764221583). VAR_031520 dbSNP
 393G -> R (in LEPRCH; Verona-1; dbSNP:rs267607184). VAR_004086 dbSNP
 409F -> V (in IRAN type A; dbSNP:rs121913142). VAR_004087 dbSNP
 439W -> S (in LEPRCH; impairs transport of the receptor to the cell surface; dbSNP:rs121913158). VAR_015542 dbSNP
 448I -> T (in dbSNP:rs1051691). VAR_015915 dbSNP
 458N -> D (in LEPRCH; partially inhibits receptor processing and autophosphorylation; strongly impairs ERK phosphorylation; induces wild-type levels of IRS-1 phosphorylation; dbSNP:rs121913160). VAR_031521 dbSNP
 487K -> E (in LEPRCH; ARK-1; dbSNP:rs28933083). VAR_004088 dbSNP
 489N -> S (in IRAN type A; dbSNP:rs28933085). VAR_004089 dbSNP
 492Q -> K. VAR_015916
 695Q -> R (in dbSNP:rs55906835). VAR_041430 dbSNP
 762R -> S (in IRAN type A; dbSNP:rs121913138). VAR_004090 dbSNP
 811G -> S (in dbSNP:rs35045353). VAR_041431 dbSNP
 830P -> L (in dbSNP:rs2162771). VAR_055986 dbSNP
 858T -> A (in NIDDM; dbSNP:rs182552223). VAR_015917 dbSNP
 925I -> T (in LEPRCH; abolishes insulin binding). VAR_015918
 926R -> W (in LEPRCH; markedly impairs insulin binding). VAR_015919
 937T -> M (in LEPRCH; impaired receptor processing). VAR_015920
 997P -> T (in RMS; reduces insulin binding). VAR_015921
 1012V -> M (rare polymorphism; dbSNP:rs1799816). VAR_004091 dbSNP
 1020R -> Q (in IRAN type A; dbSNP:rs121913148). VAR_004092 dbSNP
 1023I -> F. VAR_015922
 1035G -> V (in IRAN type A; dbSNP:rs121913135). VAR_004093 dbSNP
 1055A -> V (in IRAN type A). VAR_015923
 1065L -> V (in dbSNP:rs56395521). VAR_041432 dbSNP
 1075A -> D (in IRAN type A). VAR_004094
 1095K -> E (in a NIDDM subject). VAR_015924
 1119R -> W (in LEPRCH). VAR_015925
 1143I -> T (in RMS; reduces insulin binding). VAR_015926
 1158R -> Q (in NIDDM). VAR_015927
 1158R -> W (in RMS; abolishes insulin binding; dbSNP:rs111993466). VAR_015928 dbSNP
 1161A -> T (in IRAN type A; dbSNP:rs28933084). VAR_004095 dbSNP
 1162A -> E (in IRAN type A; impairs proteolytic processing; dbSNP:rs121913154). VAR_004096 dbSNP
 1180M -> I (in a patient with insulin resistance; dbSNP:rs121913157). VAR_004097 dbSNP
 1191R -> Q (in NIDDM; dbSNP:rs121913150). VAR_004098 dbSNP
 1201R -> Q (in HHF5 and IRAN type A; interferes with kinase activation by insulin; dbSNP:rs28933086). VAR_015929 dbSNP
 1201R -> W (in LEPRCH and RMS; reduces insulin binding possibly due to reduced receptor levels on the cell surface). VAR_015930
 1205P -> L (in IRAN type A; moderate). VAR_004099
 1206E -> D (in IRAN type A; accelerates degradation of the protein and impairs kinase activity). VAR_015931
 1206E -> K (in LEPRCH). VAR_015932
 1220W -> L (in IRAN type A; accelerates degradation of the protein and impairs kinase activity; dbSNP:rs52800171). VAR_004100 dbSNP
 1227W -> S (in IRAN type A; dbSNP:rs121913140). VAR_004101 dbSNP
 1282T -> A (in dbSNP:rs55875349). VAR_041433 dbSNP
 1361Y -> C (in dbSNP:rs13306449). VAR_015933 dbSNP
 1378R -> Q (in IRAN type A; dbSNP:rs52826008). VAR_015934 dbSNP
 957-979Helical.
 1104-1110ATP.
 1163-1164ATP.
 35-53
 153-182
 186-209
 196-215
 219-228
 223-234
 235-243
 239-252
 255-264
 268-280
 286-311
 293-301
 315-328
 331-335
 339-360
 462-495
 674-899
 825-834
 52-163Receptor L-domain
IPR000494PF01030
 179-340Furin-like cysteine-rich domain
IPR006211PF00757
 359-468Receptor L-domain
IPR000494PF01030
 1024-1290Serine-threonine/tyrosine-protein kinase , catalytic domain
IPR001245PF07714

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownload
'Structure of the human insulin receptor ectodomain, IRDeltabeta construct, in complex with four ... Heteromer
P06213;
MAN;BMA; 32×NAG; 12×FUC;4zxb28-956
Insulin in complex with Site 1 of the human insulin receptor Heteromer
P06213; P01308;
NAG;4oga28-746
Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alp... Heteromer
P06213; P01308;
NAG;3w1128-746
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insu... Heteromer
P06213; P01308;
NAG;3w1228-746
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insu... Heteromer
P06213; P01308;
NAG;3w1328-746
Insulin receptor ectodomain construct comprising domains L1,CR,L2, FNIII-1 and alphact peptide in... Heteromer
P06213; P01317; P01317; P01317; P01317;
3w1434-620
'Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insuli... Heteromer
P06213; P05019; P08069; P05019; P08069; P05019; P08069; P05019; P08069; P05019; P08069; P05019; P08069;
12×FUC;BMA;SO4; 48×NAG;4xss28-337
Structure of the endoglycosidase-H treated L1-CR domains of the human insulin receptor in complex... Heteromer
P06213; P15127;
12×SO4; 24×NAG;FUC;4xst28-337
Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv Heteromer
MAN;BMA;NAG;FUC;5j3h28-337
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide Heteromer
P81122;
3bu31005-1310
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB phosphopeptide Heteromer
P81122;
3bu61005-1310
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP Heteromer
P81122;
MG;ATP;3bu51005-1310
Crystal structure of a complex between PTP1B and the insulin receptor tyrosine kinase Heteromer
P06213; P18031;
10×SO4;2b4s1005-1310
Crystal Structure of the Insulin Receptor Kinase in Complex with the SH2 Domain of APS Heteromer
P06213; Q9Z200;
MN;112;1rqq1005-1310
Crystal structure of the Grb14 BPS region in complex with the insulin receptor tyrosine kinase Heteromer
Q14449;
CA;2auh1005-1310
Phosphorylated insulin receptor tyrosine kinase in complex with (4-{[5-carbamoyl-4-(3-methylanili... Heteromer
P35568;
S91;2z8c1008-1310
Insulin receptor (domains 1-3)homo-2-mer P33; 19×GOL;NAG;SO4;2hr728-512
Crystal structure of the activated insulin receptor tyrosine kinase dimerhomo-2-mer MG;ACP;4xlv983-1310
'PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG'homo-2-mer MG;ANP;1ir31005-1310
Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitorhomo-2-mer 351;3eta1017-1322
CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITORhomo-2-mer MG;112;1gag1005-1310
Crystal structure of insulin receptor kinase domain in complex with cis-(R)-7-(3-(azetidin-1-ylme...monomer 60O;EDO;5hhw1005-1310
Crystal structure of insulin receptor kinase domain in complex with an inhibitor Irfin-1monomer IR1;4ibm1005-1310
Crystal structure of a catalytic-loop mutant of the insulin receptor tyrosine kinasemonomer 1p141005-1310
Insulin receptor kinase complexed with an inhibitormonomer GS2;3ekk1005-1310
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTORmonomer EMC;1irk1005-1310
Insulin receptor kinase complexed with an inhibitormonomer GS3;3ekn1005-1310
The Crystal structure of INSR Tyrosine Kinase in complex with the Inhibitor BI 885578monomer 5JA;5e1s1005-1310
CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASEmonomer MG;ACP;1i441005-1310
Solution structure of the transmembrane domain of the insulin receptor in micellesmonomer 2mfr940-988

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownload
2monomerACP;-0.464xlv.1.A989-1298
99.09
2monomerNAG;-2.354zxb.1.E28-937
99.11